[]
Polman C.H., Reinhold S.C., Edan G., et al.: Diagnostic criteria for multiple
sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005;
58: 840–846.
[]
Makhani N., Gorman M.P., Branson H.M., et al.: Cyclophosphamide
therapy in pediatric multiple sclerosis. Neurology 2009; 72: 2076–2082.
[]
Kornek B., Bernert G., Rostasy K., et al.: Long-term follow-up of pediatric
patients treated with mitoxantrone for multiple sclerosis. Neuropediatrics
2011; 42: 7–12.
[]
Ghezzi A., Pozzilli C., Grimaldi L.M.E., et al.: Safety and efficacy of
natalizumab in children with multiple sclerosis. Neurology 2010; 75:
912–917.
[]
Huppke P., Stark W., Zürcher C., et al.: Natalizumab Use in Pediatric
Multiple Sclerosis. Arch Neurol 2008; 65: 1655–1658.
[]
Giovannoni G., Southam E., Waubant E.: Systemic review of diseasemodifying
therapies to asses unmet needs in multiple sclerosis:
tolerability and adherence. Mult Scler 2012; 18: 932–946.
[]
Ghezzi A.: Therapeutic strategies in childhood multiple sclerosis. Ther
Adv Neurol Disord 2010; 3: 217–228.
[]
Ghezzi A., Amato M.P., Annovazzi P., et al.: Long term results of
immunomodulatory treatment in children and adolescents with multiple
sclerosis: the Italian experience. Neurol Sci 2009; 30: 193–199.
[]
Pohl D., Waubant E., Banwell B., et al.: Treatment of pediatric multiple
sclerosis and variants. Neurology 2007; 68: 54–65.
[]
Kurtzke J.F.: Rating neurological impairment in multiple sclerosis: an
expanded disability status scale (EDSS). Neurology 1983; 33: 1444–
1452.
[]
Kasper L.H., Shoemaker J.: Multiple sclerosis immunology. Neurology
2010; 74: 2–8.
[]
Zarządzenie nr 68/2008/DGL Prezesa Narodowego Funduszu Zdrowia
z dnia 11 września 2008 roku, oraz kolejne zarządzenia zmieniające.
Address: http://www.nfz.gov.pl.
[]
Chitnis T., Tenembaum S., Banwell B., et al.: Consensus statement:
evaluation of new and existing therapeutics for pediatric multiple
sclerosis. International Pediatric Multiple Sclerosis Study Group. Mult
Scler 2012; 18: 116–127.
[]
Ghezzi A., Banwell B., Boyko A., et al.: The management of multiple
sclerosis in children: a European view. Mult Scler 2010; 16: 1258–1267.
[]
Potemkowski A.: Stwardnienie rozsiane w świecie i w Polsce – ocena
epidemiologiczna. Aktualn Neurol 2009; 9: 91–97.
[]
Ghezzi A., Deplano V., Faroni J., et al.: Multiple sclerosis in childhood:
clinical features of 149 cases. Mult Scler 1997; 1: 43–46.
[]
Boyko A., Vorobeychik G., Paty D., et al.: Early onset multiple sclerosis:
a longitudinal study. Neurology 2002; 59: 1006–1010.
[]
Banwell B., Ghezzi A., Bar-Or A., et al.: Multiple sclerosis in children:
clinical diagnosis, therapeutic strategies, and future directions. Lancet
Neurol 2007; 6: 887–902.
[]
Renoux C., Vukusic S., Mikaeloff Y., et al.: Natural history of multiple
sclerosis with childhood onset. N Engl J Med 2007; 356: 2603–2613.
Scholar Google
PubMed